{
  "slug": "the-silverstein-foundation",
  "name": "The Silverstein Foundation for Parkinson\n\r\ns with GBA",
  "description": "The Silverstein Foundation for Parkinson\n\r\ns with GBA began with the goal of aggressively seeking out new, cutting-edge therapeutic approaches to treating and preventing Parkinson\n\r\ns in GBA mutation carriers. It is now focusing its efforts on a global fellowship program to find and foster the next generation of GBA-PD researchers. The foundation also engages with clinicians, scientists, academic laboratories, and private biotechnology companies to accelerate research and clinical trials.",
  "url": "https://optimly.ai/brand/the-silverstein-foundation",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://silversteinfoundation.org/",
  "baiScore": 42,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Challenger",
  "archetype_status": "active",
  "category": "Non-profit Organization",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-07-19T00:03:35.460Z",
  "verifiedVitals": {
    "website": "https://silversteinfoundation.org/",
    "pricing_model": "Not applicable; operates as a non-profit foundation, likely funded through donations and grants to support its research and fellowship initiatives.",
    "core_products": "Global fellowship program for GBA-PD researchers, facilitation of research, and acceleration of clinical trials for Parkinson's with GBA mutations.",
    "key_differentiator": "Exclusive and aggressive focus on Parkinson's disease specifically in GBA mutation carriers, combined with a strong commitment to fostering the next generation of researchers through a global fellowship program and extensive scientific collaborations.",
    "target_markets": "Researchers and scientists in neurodegenerative diseases (specifically GBA-PD), academic institutions, biotechnology companies, and the Parkinson's patient community (GBA mutation carriers).",
    "subcategory": "Medical Research & Advocacy"
  },
  "intentTags": {
    "problemIntents": [
      "Independent Researcher Grant Applications: Researchers would individually apply for general grants from broader funding bodies, potentially leading to less coordinated and targeted research on GBA-PD ",
      "General Medical Research Foundations: Reliance on larger, more generalized medical research foundations that may fund Parkinson's research but lack the specific, aggressive focus on GBA mutations or d",
      "Passive Research Development: Allowing research into GBA-PD to progress at a natural pace without the targeted funding, accelerated initiatives, and dedicated talent development provided by the Silver"
    ],
    "solutionIntents": [
      "Silverstein Foundation Parkinson's GBA research",
      "GBA Parkinson's disease fellowships",
      "Parkinson's GBA mutation therapeutics",
      "Biotech Company Internal R&D: Biotechnology companies may pursue GBA-PD therapeutics through their internal R&D, but without external foundational support, the pace and scope of academic research and "
    ],
    "evaluationIntents": []
  },
  "timestamp": 1784892101405
}